Log In

Baudax Bio Inc. (BXRX)

Nasdaq Hearings Panel Grants Company Listing Request

‌
Gregory AurandMedia Inquiries
Senior Healthcare Services & Medical Devices Analyst
July 26, 2023
Report ID: 25979
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.
Get Report

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

‌
Baudax Bio Inc.
Baudax Bio Inc.
Healthcare
Biotechnology
Ticker
BXRX
Current Price
$0.0326 -5.23%
Market Cap
$1.4M
Price Target
Refer to Report
Volume
513.7K
52wk Range
$0.033 - $7.64
Fundamental Analysis:
Log in to view
Rating: Log in to view
Advanced Market Data
Related Research Reports
10/16/2023
‌
Shareholders Approve Merger-Related Preferred Stock Conversion
Shareholders Approve Merger-Related Preferred Stock Conversion (BXRX)
0 min read
9/29/2023
‌
Orphan Drug Designation Granted By FDA for TI-168
Orphan Drug Designation Granted By FDA for TI-168 (BXRX)
0 min read
8/23/2023
‌
A New Phase Begins For Baudax Bio With Reported 2Q 2023
A New Phase Begins For Baudax Bio With Reported 2Q 2023 (BXRX)
5 min read
7/26/2023
‌
Nasdaq Hearings Panel Grants Company Listing Request
Nasdaq Hearings Panel Grants Company Listing Request (BXRX)
0 min read

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
Log In
© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
Log In